ALDH3B2 participates in an eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma and a gene expression signature-based nomogram model in the prediction of breast cancer bone metastases [52, 53]. Here, ALDH3B2 is linked to clear cell renal carcinoma.